,i #aaith ,,congress #ast ,session ,h4 ,r4 #diic ,,in ,,the ,,house ,,of ,,representatives ,august #ai1 #bjbe,mr4 ,fitzpatrick 7for himself1 ,mr4 ,dunn of ,florida1 and ,mr4 ,soto7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to provide coverage of external infusion pumps and non-self-administrable home infusion drugs under the ,medicare program4 #a4 ,short title ,this ,act may be cited as the ,joe ,fiandra ,access to ,home ,infusion ,act of #bjbe4 #b4 ,medicare coverage of external infusion pumps and non-self-administrable home infusion drugs 7a7 ,in general ,section #ahfa7n7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7n77 is amended by adding at the end the following new sentence3 ,beginning with the first calendar quarter beginning on or after the date that is #a year after the date of the enactment of this sentence1 an external infusion pump and associated home infusion drug 7as defined in subsection 7iii77#c77;,c77 or other associated supplies that do not meet the appropriate for use in the home requirement applied to the definition of durable medical equipment under section #dad4bjb of title #db1 ,code of ,federal ,regulations 7or any successor to such regulation7 shall be treated as meeting such requirement if each of the following criteria is satisfied3 7#a7 ,the prescribing information approved by the ,food and ,drug ,administration for the home infusion drug associated with the pump instructs that the drug should be administered by or under the supervision of a health care professional4 7#b7 ,a qualified home infusion therapy supplier 7as defined in subsection 7iii77#c77;,d77 administers or supervises the administration of the drug or biological in a safe and effective manner in the patient's home 7as defined in subsection 7iii77#c77;,b774 7#c7 ,the prescribing information described in paragraph 7#a7 instructs that the drug should be infused at least #ab times per year-- 7,a7 intravenously or subcutaneously2 or 7,b7 at infusion rates that the ,secretary determines would require the use of an external infusion pump4 4 7b7 ,cost sharing notification ,the ,secretary of ,health and ,human ,services shall ensure that patients are notified of the cost sharing for electing home infusion therapy compared to other applicable settings of care for the furnishing of infusion drugs under the ,medicare program4